These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 26032630

  • 1. Initial study on the possible mechanisms involved in the effects of high doses of perfluorooctane sulfonate (PFOS) on prolactin secretion.
    Salgado R, Pereiro N, López-Doval S, Lafuente A.
    Food Chem Toxicol; 2015 Sep; 83():10-6. PubMed ID: 26032630
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Perfluorooctane sulfonate effects on the reproductive axis in adult male rats.
    López-Doval S, Salgado R, Pereiro N, Moyano R, Lafuente A.
    Environ Res; 2014 Oct; 134():158-68. PubMed ID: 25171141
    [Abstract] [Full Text] [Related]

  • 6. Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis.
    De Laurentiis A, Pisera D, Caruso C, Candolfi M, Mohn C, Rettori V, Seilicovich A.
    Neuroimmunomodulation; 2002 Oct; 10(1):30-9. PubMed ID: 12207161
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chronic Exposure of Female Mice to an Environmental Level of Perfluorooctane Sulfonate Suppresses Estrogen Synthesis Through Reduced Histone H3K14 Acetylation of the StAR Promoter Leading to Deficits in Follicular Development and Ovulation.
    Feng X, Wang X, Cao X, Xia Y, Zhou R, Chen L.
    Toxicol Sci; 2015 Dec; 148(2):368-79. PubMed ID: 26358002
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Superior cervical ganglionectomy differentially modifies median eminence and anterior and mediobasal hypothalamic GABA content in male rats: effects of hyperprolactinemia.
    Esquifino AI, Alvarez MP, Cano P, Jiménez V, Duvilanski B.
    Exp Brain Res; 2004 Aug; 157(3):296-302. PubMed ID: 14985901
    [Abstract] [Full Text] [Related]

  • 15. Intraventricular administration of estradiol modulates rat prolactin secretion and synthesis.
    Maeda T, Ikegami H, Sakata M, Yamaguchi M, Wada K, Koike K, Adachi K, Kurachi H, Hirota K, Miyake A.
    J Endocrinol Invest; 1996 Oct; 19(9):586-92. PubMed ID: 8957741
    [Abstract] [Full Text] [Related]

  • 16. Impact of Perfluorooctane Sulfonate on Reproductive Ability of Female Mice through Suppression of Estrogen Receptor α-Activated Kisspeptin Neurons.
    Wang X, Bai Y, Tang C, Cao X, Chang F, Chen L.
    Toxicol Sci; 2018 Oct 01; 165(2):475-486. PubMed ID: 29939337
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of perfluorooctane sulfonate on the immune responses and expression of immune-related genes in Chinese mitten-handed crab Eriocheir sinensis.
    Zhang F, Wei J, Li Q, Jiang R, Yu N, Qin J, Chen L.
    Comp Biochem Physiol C Toxicol Pharmacol; 2015 Oct 01; 172-173():13-8. PubMed ID: 25900200
    [Abstract] [Full Text] [Related]

  • 20. Acute effects of delta 9-tetrahydrocannabinol on tuberoinfundibular dopamine activity, anterior pituitary sensitivity to dopamine and prolactin release vary as a function of estrous cycle.
    Bonnin A, Ramos JA, Rodríguez de Fonseca F, Cebeira M, Fernández-Ruiz JJ.
    Neuroendocrinology; 1993 Sep 01; 58(3):280-6. PubMed ID: 7902959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.